Positron emission tomography/computed tomography (PET/CT) using [18F]-fluoro-2-deoxy-D-glucose (FDG) has become the mainstay imaging modality for evaluating oncology patients with certain cancers. The most common FDG PET/CT applications include staging/restaging, assessing response to therapy and detecting tumor recurrence. It is important to be aware of potential pitfalls and technical artifacts on PET/CT in the chest and abdomen to ensure accurate interpretation, avoid unnecessary intervention and optimize patient care.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1053/j.sult.2024.07.012 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!